Clinical trial
Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study
NCT00470587 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advantageous Predictors of Acute Coronary Syndromes Evaluation (APACE) Study
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- December 31, 2025
- Enrollment
- 10,000 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.